Patient Access & Affordability
  • About
    • Mission
    • Who We Are
    • Professional Advisory Council
    • Patient Advisors
    • Members
    • Funding
    • Contact
  • Resources
    • Blog
    • Watch & Listen
    • Surveys
  • Publications
    • Research Briefings
    • Current Issues
    • Fast Facts
    • Policy Platform
  • Working Groups
    • Benefit Design
    • Rare Disease Health Technology Assessment
      • Featured Work
    • Biosimilars & Complex Generics
  • ICERWATCH
    • What is ICER?
    • ICER Glossary
    • Analysis and Commentary
    • Public Comments
Select Page
Personalized treatments are helping acute migraine patients. ICER says they’re not worth the cost.

Personalized treatments are helping acute migraine patients. ICER says they’re not worth the cost.

Jan 27, 2020

Migraine, especially acute migraine, can be severe and devastating.    “I know firsthand that migraine attacks are debilitating not just for me, but for my entire family,” Kristin Molacek, a mother of five young children and migraine patient in...

Categories

  • Access & Affordability
  • Blog
  • Comments
  • ICERWatch
  • News
  • Opinion
  • QALY
  • Research
  • Resources
  • Statements
  • Uncategorized
  • Video

IPAA

700 12th St. NW, Suite 700
Washington, DC 20005
202-750-1186 |  info@accessandaffordability.org

The Patient Access & Affordability Project is a program of Patients Rising, a national 501(c)3 nonprofit organization, and is governed by the Patients Rising Board of Directors.

  • Facebook
  • Twitter
  • RSS